Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
5 hedge funds and large institutions have $1.53M invested in Yield10 Bioscience, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 6 closing their positions.
23% more capital invested
Capital invested by funds: $1.24M → $1.53M (+$286K)
50% less funds holding
Funds holding: 10 → 5 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$21K |
| 2 |
CC
Cannell & Co
New York
|
-$18.7K |
| 3 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$16K |
| 4 |
Renaissance Technologies
New York
|
-$14K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$13K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
1
Birchview Capital
Burlington,
Vermont
| $1.05M | – | – | – |
|
|
CC
2
Cannell & Co
New York
| $379K | -$18.7K | -4 | -5% |
|
3
BlackRock
New York
| $78K | -$4.68K | -1 | -6% |
|
4
UBS Group
Zurich,
Switzerland
| $9K | – | – | – |
|
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $4K | +$4.68K | +1 | New |
|
6
Group One Trading
Chicago,
Illinois
| $1K | – | – | – |
|
7
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1K | – | – | – |
|
8
Morgan Stanley
New York
| $1K | – | – | – |
|
|
PSC
9
Prentiss Smith & Co
Brattleboro,
Vermont
| $1K | – | – | – |
|
|
TWA
10
TCI Wealth Advisors
Tucson,
Arizona
| $1K | – | – | – |
|
|
WEC
11
Winslow Evans & Crocker
Boston,
Massachusetts
| $15 | – | – | – |
|
|
12
Goldman Sachs
New York
| – | -$21K | -6 | Closed |
|
|
FA
13
FCG Advisors
Chatham,
New Jersey
| – | -$16K | -5 | Closed |
|
|
14
Geode Capital Management
Boston,
Massachusetts
| – | -$13K | -4 | Closed |
|
|
15
Renaissance Technologies
New York
| – | -$14K | -4 | Closed |
|
16
Citadel Advisors
Miami,
Florida
| – | -$11K | -3 | Closed |
|
17
Vanguard Group
Malvern,
Pennsylvania
| – | -$4K | -1 | Closed |
|
YTEN Hedge Fund Activity: Q2 2017 in Review
5 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q2 2017, worth a combined $1.53M — up 23% from $1.24M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of YTEN and 1 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Deutsche Bank, opening a new position worth an estimated $4.68K. The largest seller was Goldman Sachs, exiting entirely with an estimated $21K sold.
- 5 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q2 2017, down from 10 in Q1 2017.
- Funds reported $1.53M of Yield10 Bioscience, Inc. Common Stock stock for Q2 2017, up 23% quarter-over-quarter.
- 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q2 2017 and 6 closed out, a net change of -5 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q2 2017 was Deutsche Bank, an estimated $4.68K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q2 2017 was Goldman Sachs, an estimated $21K sold.
Based on aggregated 13F filings for Q2 2017.